Washington University in St Louis · Microbiology & ImmunologyStallings Tuberculosis Lab
Christina Leigh Stallings · Saint Louis, Missouri
Research Focus
Dr. Christina Leigh Stallings' lab focuses on understanding and combating tuberculosis (TB), a deadly disease caused by Mycobacterium tuberculosis (Mtb). The lab is developing innovative treatments that target drug-resistant strains of TB by creating new compounds that act through unique mechanisms. Additionally, the research investigates how immune responses, particularly during co-infection with HIV, affect TB progression and treatment outcomes.
tuberculosisHIV co-infectionimmune responsedrug resistanceantimicrobials
Research Aims
5AIM 01Develop novel anti-TB compounds targeting drug-resistant strains
AIM 02Investigate early immune responses to Mtb infection
AIM 03Understand granuloma formation in TB
AIM 04Explore the impact of HIV on TB disease outcomes
AIM 05Identify new mechanisms of action for TB therapies
Skills the Lab Values
cell culturehigh-throughput screeningstructure-activity relationship (SAR) analysisgenetic sequencingprotein purification
Output against the department
Publications2bottom 2% of dept.476th of 486
this lab
most publishedleast published
Citations0bottom 1% of dept.477th of 486
this lab
most citedleast cited
Career totals from OpenAlex, compared against labs that share a department. A department spans everything from one paper to tens of thousands, so bar heights are on a log scale — otherwise the largest lab would flatten every other bar to a line.